电商行业报告合集(共29份)
电商各业态,点我来看
-
艾媒咨询|2024年中国生活美容及轻医美市场研究报告
随着居民生活水平的提高和审美观念的转变,美容行业逐渐形成一个庞大的产业链,从基本的护肤、化妆到整形、微整形等,美容行业的服务范围越发广泛。全球新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询)最新发布的《2024年中国生活美容及轻医美市场研究报告》数据显示,2023年中国美容行业市场规模已达2804.0亿元,预计2025年市场规模有望达到3816.0亿元。未来,科技美容将成为美容行业的一个重要发展方向。数据显示,2017-2023年间中国轻医美市场用户规模不断增长,2023年其用户规模达2354万人,预计到2025年将达3105万人。用户规模的持续增长,表明中国轻医美市场呈现快速发展趋势,整个市场仍有巨大的发展潜力。
With the improvement of residents' living standards and the change of aesthetic concepts, the beauty industry has gradually become a huge industrial chain, from basic skin care, makeup to plastic surgery, micro-plastic surgery, etc., the service range of the beauty industry is more and more extensive. According to the latest "China Life Beauty and light Medicine Beauty Market Research Report 2024" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the market size of China's beauty industry has reached 280.04 billion yuan in 2023. It is expected that the market size is expected to reach 381.60 billion yuan in 2025. In the future, science and technology beauty will become an important development direction of the beauty industry. Data show that the user scale of China's light medical beauty market continues to grow between 2017 and 2023, with the user scale reaching 23.54 million in 2023 and is expected to reach 31.05 million in 2025. The continuous growth of the user scale indicates that China's light medical beauty market is showing a rapid development trend, and the entire market still has huge development potential. -
艾媒咨询|2021-2022年中国医美器械产业运行及投资决策分析报告
本报告研究涉及企业/品牌/案例:科医人,复星医药,奇致激光,半岛医疗
伴随着医美市场规模的持续扩大,中国医美器械行业发展前景可期。数据显示,预计2021年中国医美器械市场规模将超过500亿元,同比增长27.8%。从细分赛道来看,近年来,微创和无创已逐渐成为医疗美容的趋势,这就推动了以激光、超声波等能量源为代表的光电类医美器械的发展。从市场格局来看,中国正规医美机构设备的市场份额80%是进口品牌,且中高端市场被飞顿、塞诺龙等海外龙头企业占领。为了改变这一局面,国家及地方先后出台政策鼓励本土医美器械品牌的发展,同时,国有品牌也通过加大自主研发投入和投资并购来扩大市场份额,未来随着下游扩张、需求渗透、技术更新等因素有望加速进口替代。
With the continuous expansion of the medical beauty market, the development prospect of the medical beauty equipment industry in China is promising. According to the data, it is estimated that in 2021, the market size of medical devices in China will exceed 50 billion yuan, with a year-on-year growth of 27.8%. From the perspective of subdivision, in recent years, minimally invasive and non-invasive have gradually become the trend of medical beauty, which promotes the development of photoelectric medical beauty devices represented by laser, ultrasonic and other energy sources. From the perspective of market structure, 80% of the market share of China's regular medical and beauty institutions' equipment is imported brands, and the medium and high-end market is occupied by overseas leading enterprises such as feton and sinolon. In order to change this situation, the state and local governments have successively issued policies to encourage the development of local medical and beauty equipment brands. At the same time, the state-owned brands also expand their market share by increasing independent R & D investment and investment in M & A. in the future, with the downstream expansion, demand penetration, technology update and other factors, it is expected to accelerate the import substitution. -
艾媒咨询|2021全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例:阿里健康,联合丽格,恒瑞医药,白云山,平安好医生,111集团,新氧,药明巨诺,盘龙药业,先导药业,好大夫在线,优健康,春雨医生,丁香医生,微医
受到人口老龄化、居民患病比例增加等因素影响,国家医疗费用支出不断增加,属于刚性需求;同时,随着人们对健康标准的不断提高以及互联网医疗技术的发展,大健康产业会在相当长的时期内持续保持增长态势。数据显示,2020年中国的大健康产业营收规模超过7万亿元,预计2021年将达8万亿元,增幅达8.1%。其中,得益于大健康产业发展以及疫情期间医药需求增长,生物制药、医疗器械两大细分领域表现良好,成为2020年中国投资热度较高的新经济行业,投资项目金额分别为919亿元和273亿元。
Affected by the aging population and the increasing proportion of residents, the national medical expenditure is increasing, which belongs to the rigid demand; At the same time, with the continuous improvement of people's health standards and the development of internet medical technology, the big health industry will continue to grow for a long time. According to the data, the revenue of China's big health industry will exceed 7 trillion yuan in 2020, and it is expected to reach 8 trillion yuan in 2021, an increase of 8.1%. Among them, thanks to the development of big health industry and the growth of pharmaceutical demand during the epidemic period, biopharmaceuticals and medical devices have performed well, becoming China's new economy industry with high investment enthusiasm in 2020, with investment projects of 91.9 billion yuan and 27.3 billion yuan respectively. -
艾媒咨询|2021年中国轻医美行业研究及产业链分析报告
本报告研究涉及企业/品牌/案例:爱美客,华熙生物,奇致激光,华韩整形,新氧,兰州生物
数据显示,2020年中国轻医美用户市场规模达到1520万人,预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下,机构、医生在供给端强势助推轻医美行业更快速发展,预计2021年中国轻医美市场将达到798亿元,同比增长46.4%。在行业快速增长的同时,轻医美产业链各环节企业由于集中度不同导致利润分配不均,具体来看,上游原料耗材企业由于高技术壁垒,市场集中度较高,毛利率高于中下游企业,如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等,而中下游由于竞争分散,单体获利参差不齐,更容易产生乱象。但总体来说,在行业监管加强、机构自律、平台监督等多方力量共同作用下,轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization. -
艾媒报告|2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告
本报告研究涉及企业/品牌/案例:美敦力,GE医疗,迈瑞医疗,万孚生物,鱼跃医疗,乐普医疗,九安医疗;其他提及企业/品牌:冠昊生物,华海药业,金域医学,卫宁健康,新和成,健帆生物,费森尤斯医疗,嘉德诺,丹纳赫,史赛克,依视路陆逊梯卡,创业慧康,康恩贝,华北制药,通用电气,西门子,飞利浦,3M,绿盾,霍尼韦尔,保为康POWECOM,CM朝美,UVEX优唯斯,南丁,云南白药,维康WECAN,振德医疗,迪卡侬,锐步,速尔,爱康,KEEP,李宁,亿健,舒华,WALKINGPAD,英派斯,SKG,本博,倍轻松,南极人,凯仕乐,佳仁,茗振,小熊,璐瑶,攀高
2020年4月21日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对全球范围内的医疗器械产品进行全面分析,并且报告聚焦于疫情问题下的呼吸机、额温枪等医疗器械,具体针对美敦力、GE医疗、迈瑞医疗、万孚生物、鱼跃医疗和乐普医疗等典型案例分析,对2020-2021年医疗器械行业发展进行趋势预判。特别在全球新冠肺炎疫情的严峻情势下,呼吸机、额温枪等医疗器械需求猛增,飞利浦、美敦力等西方医疗器械企业快速提高产量,以支持抗疫工作的迫切需求;同时,中国呼吸机等医疗器械企业的海外业务量有明显增长。艾媒咨询分析师认为,全球疫情势必带动医疗器械行业发展,但中国企业应当在保证自身产品质量的基础上抓住机遇,实现业务出海。
According to the data, the global medical device market has continued to increase in size since 2016, and the global medical device market is expected to reach USD 477.4 billion in 2020. Especially under the influence of the New Crown epidemic, the global demand for medical equipment such as ventilators and oxygen concentrators has increased dramatically. Overseas orders for Chinese medical device companies have skyrocketed. Within a certain period, the concept stocks of ventilator in the A-share market have risen. -
艾媒咨询|2020H1中国老年人群画像及消费模式调查分析报告
调研数据显示,有66.8%的被访者认为100万元以内的养老资产储备基本足够。艾媒咨询分析师认为,在独生子女供养老人的需求与国家养老保险基金的收支压力之间存在的普遍矛盾背景下,国民对留存养老资金意愿强烈,这也意味着养老资金有保障,对养老产业的需求长期存在。
The survey data shows that 66.8% of the respondents think that the reserve of pension assets within 1 million yuan is basically sufficient. Ai Media Consulting analysts believe that in the context of the general contradiction between the needs of the only child to support the elderly and the pressure of the national pension insurance fund's revenue and expenditure, the nationals have a strong desire to retain pension funds, which also means that pension funds are guaranteed. The demand for the pension industry has long existed. -
艾媒报告|2020-2021年中国医疗电商行业发展趋势及标杆企业分析报告
本报告研究涉及企业/品牌/案例:平安好医生,康爱多,阿里健康,健客,鱼跃医疗;其他提及企业/品牌:益药购,1药网,九州通网,心诺,我的医药网,好药师,美之氧,药京采,七乐康,欧姆龙,普天药城网,氧生活,未名企鹅,爱康多,巨人,药药好,京东大药房,康祝,药品终端网,360好药,可孚,药师帮,药房网,艾润科技,药便宜,八百方
2020年3月9日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国医疗电商行业发展趋势及标杆企业分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对2020年中国医疗电商产业发展进行分析。本报告主要通过医药电商和家用医疗器械两方面,对医疗电商产业上下游深入探究运行模式,并对鱼跃集团、平安好医生、爱康多等典型企业进行案例分析,以此对中国医疗电商行业发展进行趋势预判。2019年中国医药电商行业发展规模继续增大,涌现出许多新型零售方式。越来越多医药企业涌入B2B主流市场,B2C市场规模也随着消费者健康意识的提升以及网购消费习惯的固定而得到较大发展;越来越多药企也开始开展O2O业务。以药到医、“医+药”发展的模式也受到普遍认可。特别在新型冠状病毒肺炎疫情影响下,医疗电商以其独特的互联网优势在抗击疫情中发挥了重要作用。在此契机下,医疗电商行业将在2020年迎来重大普及发展的历史机遇期。
In 2019, the scale of China's pharmaceutical e-commerce industry continues to increase, and many new retail methods have emerged. More and more pharmaceutical companies have entered the mainstream B2B market, and the scale of the B2C market has also grown significantly with the improvement of consumers' health awareness and the fixation of online shopping consumption habits; more and more pharmaceutical companies have begun to develop O2O business. The development model from medicine to medicine and "medicine + medicine" has also been widely recognized. Especially under the influence of the new coronavirus pneumonia epidemic, medical e-commerce has played an important role in fighting the epidemic with its unique Internet advantage. With this opportunity, the medical e-commerce industry will usher in a period of historical opportunities for significant popularization in 2020.
- 1
- 2
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告